The role of interleukin 13 and the type 2 immune pathway in COVID-19: A review
Although much has been learned about severe acute respiratory syndrome coronavirus 2 since December 2019, uneven global vaccine distribution, rapid viral spread, and variant evasion of preventative measures have led to its persistence in the population for the foreseeable future. Additional therapie...
Gespeichert in:
| Veröffentlicht in: | Annals of allergy, asthma, & immunology asthma, & immunology, 2023-06, Vol.130 (6), p.727-732 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 732 |
|---|---|
| container_issue | 6 |
| container_start_page | 727 |
| container_title | Annals of allergy, asthma, & immunology |
| container_volume | 130 |
| creator | Sasson, Jennifer Moreau, G. Brett Petri, William A. |
| description | Although much has been learned about severe acute respiratory syndrome coronavirus 2 since December 2019, uneven global vaccine distribution, rapid viral spread, and variant evasion of preventative measures have led to its persistence in the population for the foreseeable future. Additional therapies are needed to support patients through their acute, immune-mediated disease process that continues to lead to considerable morbidity and mortality. Data revealing the involvement of type 2 immune pathway in acute coronavirus disease 2019 and post-recovery conditions represent a potential additional area for intervention. Herein, we review the current understanding of interleukin 13 in acute severe acute respiratory syndrome coronavirus 2 infection, the clinical outcomes associated with type 2 immune processes, and the impact of type 2 blockade on acute and long-term coronavirus disease 2019 conditions. |
| doi_str_mv | 10.1016/j.anai.2023.03.009 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2795358979</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1081120623001722</els_id><sourcerecordid>2795358979</sourcerecordid><originalsourceid>FETCH-LOGICAL-c400t-2320cba6b571ae61d7bb9107ac91f4c6d8e159b875cdd6f59845c1c49b3a72473</originalsourceid><addsrcrecordid>eNp9kEtrHDEQhEWIie1N_kAOQcdcZt16jDQKuZj1E4z3YucqNJoerM08NtKMl_330bJOjoaGbuivCqoI-cpgyYCpi83SDS4sOXCxhDxgPpAzVgpZSCnUx3xDxQrGQZ2S85Q2AMAqJT6RU6EMl0boM_L49II0jh3SsaVhmDB2OP8OA2WCuqGhU35P-y1STkPfzwPSrZtedm6fYbpa_7q_Kpj5QS9pxNeAu8_kpHVdwi9ve0Geb66fVnfFw_r2fnX5UHgJMBVccPC1U3WpmUPFGl3XhoF23rBWetVUyEpTV7r0TaPa0lSy9MxLUwunudRiQb4ffbdx_DNjmmwfkseucwOOc7Jcm1KUldEmo_yI-jimFLG12xh6F_eWgT30aDf20KM99GghDxxE397857rH5r_kX3EZ-HkEMKfMyaNNPuDgsQkR_WSbMbzn_xd_nIDq</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2795358979</pqid></control><display><type>article</type><title>The role of interleukin 13 and the type 2 immune pathway in COVID-19: A review</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Sasson, Jennifer ; Moreau, G. Brett ; Petri, William A.</creator><creatorcontrib>Sasson, Jennifer ; Moreau, G. Brett ; Petri, William A.</creatorcontrib><description>Although much has been learned about severe acute respiratory syndrome coronavirus 2 since December 2019, uneven global vaccine distribution, rapid viral spread, and variant evasion of preventative measures have led to its persistence in the population for the foreseeable future. Additional therapies are needed to support patients through their acute, immune-mediated disease process that continues to lead to considerable morbidity and mortality. Data revealing the involvement of type 2 immune pathway in acute coronavirus disease 2019 and post-recovery conditions represent a potential additional area for intervention. Herein, we review the current understanding of interleukin 13 in acute severe acute respiratory syndrome coronavirus 2 infection, the clinical outcomes associated with type 2 immune processes, and the impact of type 2 blockade on acute and long-term coronavirus disease 2019 conditions.</description><identifier>ISSN: 1081-1206</identifier><identifier>ISSN: 1534-4436</identifier><identifier>EISSN: 1534-4436</identifier><identifier>DOI: 10.1016/j.anai.2023.03.009</identifier><identifier>PMID: 36924937</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>COVID-19 ; Humans ; Interleukin-13 ; SARS-CoV-2</subject><ispartof>Annals of allergy, asthma, & immunology, 2023-06, Vol.130 (6), p.727-732</ispartof><rights>2023 The Authors</rights><rights>Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c400t-2320cba6b571ae61d7bb9107ac91f4c6d8e159b875cdd6f59845c1c49b3a72473</citedby><cites>FETCH-LOGICAL-c400t-2320cba6b571ae61d7bb9107ac91f4c6d8e159b875cdd6f59845c1c49b3a72473</cites><orcidid>0000-0001-7352-2596 ; 0000-0002-7268-1218 ; 0000-0001-6032-4320</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.anai.2023.03.009$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36924937$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Sasson, Jennifer</creatorcontrib><creatorcontrib>Moreau, G. Brett</creatorcontrib><creatorcontrib>Petri, William A.</creatorcontrib><title>The role of interleukin 13 and the type 2 immune pathway in COVID-19: A review</title><title>Annals of allergy, asthma, & immunology</title><addtitle>Ann Allergy Asthma Immunol</addtitle><description>Although much has been learned about severe acute respiratory syndrome coronavirus 2 since December 2019, uneven global vaccine distribution, rapid viral spread, and variant evasion of preventative measures have led to its persistence in the population for the foreseeable future. Additional therapies are needed to support patients through their acute, immune-mediated disease process that continues to lead to considerable morbidity and mortality. Data revealing the involvement of type 2 immune pathway in acute coronavirus disease 2019 and post-recovery conditions represent a potential additional area for intervention. Herein, we review the current understanding of interleukin 13 in acute severe acute respiratory syndrome coronavirus 2 infection, the clinical outcomes associated with type 2 immune processes, and the impact of type 2 blockade on acute and long-term coronavirus disease 2019 conditions.</description><subject>COVID-19</subject><subject>Humans</subject><subject>Interleukin-13</subject><subject>SARS-CoV-2</subject><issn>1081-1206</issn><issn>1534-4436</issn><issn>1534-4436</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kEtrHDEQhEWIie1N_kAOQcdcZt16jDQKuZj1E4z3YucqNJoerM08NtKMl_330bJOjoaGbuivCqoI-cpgyYCpi83SDS4sOXCxhDxgPpAzVgpZSCnUx3xDxQrGQZ2S85Q2AMAqJT6RU6EMl0boM_L49II0jh3SsaVhmDB2OP8OA2WCuqGhU35P-y1STkPfzwPSrZtedm6fYbpa_7q_Kpj5QS9pxNeAu8_kpHVdwi9ve0Geb66fVnfFw_r2fnX5UHgJMBVccPC1U3WpmUPFGl3XhoF23rBWetVUyEpTV7r0TaPa0lSy9MxLUwunudRiQb4ffbdx_DNjmmwfkseucwOOc7Jcm1KUldEmo_yI-jimFLG12xh6F_eWgT30aDf20KM99GghDxxE397857rH5r_kX3EZ-HkEMKfMyaNNPuDgsQkR_WSbMbzn_xd_nIDq</recordid><startdate>202306</startdate><enddate>202306</enddate><creator>Sasson, Jennifer</creator><creator>Moreau, G. Brett</creator><creator>Petri, William A.</creator><general>Elsevier Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-7352-2596</orcidid><orcidid>https://orcid.org/0000-0002-7268-1218</orcidid><orcidid>https://orcid.org/0000-0001-6032-4320</orcidid></search><sort><creationdate>202306</creationdate><title>The role of interleukin 13 and the type 2 immune pathway in COVID-19: A review</title><author>Sasson, Jennifer ; Moreau, G. Brett ; Petri, William A.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c400t-2320cba6b571ae61d7bb9107ac91f4c6d8e159b875cdd6f59845c1c49b3a72473</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>COVID-19</topic><topic>Humans</topic><topic>Interleukin-13</topic><topic>SARS-CoV-2</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sasson, Jennifer</creatorcontrib><creatorcontrib>Moreau, G. Brett</creatorcontrib><creatorcontrib>Petri, William A.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of allergy, asthma, & immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sasson, Jennifer</au><au>Moreau, G. Brett</au><au>Petri, William A.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The role of interleukin 13 and the type 2 immune pathway in COVID-19: A review</atitle><jtitle>Annals of allergy, asthma, & immunology</jtitle><addtitle>Ann Allergy Asthma Immunol</addtitle><date>2023-06</date><risdate>2023</risdate><volume>130</volume><issue>6</issue><spage>727</spage><epage>732</epage><pages>727-732</pages><issn>1081-1206</issn><issn>1534-4436</issn><eissn>1534-4436</eissn><abstract>Although much has been learned about severe acute respiratory syndrome coronavirus 2 since December 2019, uneven global vaccine distribution, rapid viral spread, and variant evasion of preventative measures have led to its persistence in the population for the foreseeable future. Additional therapies are needed to support patients through their acute, immune-mediated disease process that continues to lead to considerable morbidity and mortality. Data revealing the involvement of type 2 immune pathway in acute coronavirus disease 2019 and post-recovery conditions represent a potential additional area for intervention. Herein, we review the current understanding of interleukin 13 in acute severe acute respiratory syndrome coronavirus 2 infection, the clinical outcomes associated with type 2 immune processes, and the impact of type 2 blockade on acute and long-term coronavirus disease 2019 conditions.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>36924937</pmid><doi>10.1016/j.anai.2023.03.009</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0001-7352-2596</orcidid><orcidid>https://orcid.org/0000-0002-7268-1218</orcidid><orcidid>https://orcid.org/0000-0001-6032-4320</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1081-1206 |
| ispartof | Annals of allergy, asthma, & immunology, 2023-06, Vol.130 (6), p.727-732 |
| issn | 1081-1206 1534-4436 1534-4436 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_2795358979 |
| source | MEDLINE; Elsevier ScienceDirect Journals Complete |
| subjects | COVID-19 Humans Interleukin-13 SARS-CoV-2 |
| title | The role of interleukin 13 and the type 2 immune pathway in COVID-19: A review |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T23%3A03%3A33IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20role%20of%20interleukin%2013%20and%20the%20type%202%20immune%20pathway%20in%20COVID-19:%20A%20review&rft.jtitle=Annals%20of%20allergy,%20asthma,%20&%20immunology&rft.au=Sasson,%20Jennifer&rft.date=2023-06&rft.volume=130&rft.issue=6&rft.spage=727&rft.epage=732&rft.pages=727-732&rft.issn=1081-1206&rft.eissn=1534-4436&rft_id=info:doi/10.1016/j.anai.2023.03.009&rft_dat=%3Cproquest_cross%3E2795358979%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2795358979&rft_id=info:pmid/36924937&rft_els_id=S1081120623001722&rfr_iscdi=true |